Evidence map›Paper›PMID 35814522›Full record

ReviewJournal of clinical and experimental hepatology

Overview of Complications in Cirrhosis.

Madhumita Premkumar, Anil C Anand

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06095466 (Diagnosis and Pathogenetic Mechanisms in Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology), which is not on this map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06095466 recruitingnot on this map

Diagnosis and Pathogenetic Mechanisms in Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology

TypeobservationalSponsorPost Graduate Institute of Medical Education and Research, ChandigarhRan2023 to 2026Enrolled150ConditionsCirrhotic Cardiomyopathy, Cirrhosis, Liver, Cardiac DiseaseArmsEchocardiographic assessment, Histopathology and Immunohistochemistry
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Spontaneous bacterial peritonitis due toRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Madhumita PremkumarDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Anil C AnandDepartment of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneshwar, Odisha, India.
All India Institute of Medical Sciences Bhubaneswar · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cirrhosis is the outcome of chronic liver disease of any etiology due to progressive liver injury and fibrosis. Consequently, cirrhosis leads to portal hypertension and liver dysfunction, progressing to complications like ascites, variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, cirrhotic cardiomyopathy, sarcopenia, hepatocellular carcinoma, and coagulation disorders. End-stage liver disease leads to an impaired quality of life, loss of social and economic productivity, and reduced survival. Methods: This narrative review explains the pathophysiology of complications of cirrhosis, the diagnostic approach and innovative management, with focus on data from India. A comprehensive literature search of the published data was performed in regard with the spectrum, diagnosis, and management of cirrhosis and its complications. Results: There is a change in the epidemiology of metabolic syndrome, lifestyle diseases, alcohol consumption and the spectrum of etiological diagnosis in patients with cirrhosis. With the advent of universal vaccination and efficacious long-term viral suppression agents for chronic hepatitis B, availability of direct-acting antiviral agents for chronic hepatitis C, and a booming liver transplantation programme across the country, the management of complications is essential. There are several updates in the standard of care in the management of complications of cirrhosis, such as hepatorenal syndrome, hepatocellular carcinoma, and hepatic encephalopathy, and new therapies that address supportive and palliative care in advanced cirrhosis. Conclusion: Prevention, early diagnosis, appropriate management of complications, timely transplantation are cornerstones in the management protocol of cirrhosis and portal hypertension. India needs improved access to care, outreach of public health programmes for viral hepatitis care, health infrastructure, and disease registries for improved healthcare outcomes. Low-cost initiatives like immunization, alcohol cessation, awareness about liver diseases, viral hepatitis elimination, and patient focused decision-making algorithms are essential to manage liver disease in India.

Indexed as

AIH, autoimmune hepatitisALP, alkaline phosphataseAVB, acute variceal bleedingBMI, body mass indexcirrhosis, ascitesCLD, chronic liver diseaseCSPH, clinically significant portal hypertensionCTP, Child Turcotte Pugh ScoreDAAs, direct-acting antiviral agentsGGT, gamma glutamyl transpeptidaseHBV, hepatitis B virusHCC, hepatocellular carcinomaHCV, hepatitis C virusHE, hepatic encephalopathyhepatic encephalopathyhepatocellular carcinomaHR, hazard ratioHRQoL, health-related quality of lifeHVPG, hepatic vein pressure gradientMELD, Model for End Stage Liver diseaseMetS, metabolic syndromeNAFLD, non-alcoholic fatty liver diseaseNASH, non-alcoholic steatohepatitisNSBB, Non-selective beta blockersNVHCP, National Viral Hepatitis Control programmeportal hypertensionSAAG, Serum-ascites albumin gradientSBP, spontaneous bacterial peritonitisWHO, World Health Organization

Identifiers

PMID35814522
PMCPMC9257866
OpenAlexW4280629480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.